300142.SZ
Walvax Biotechnology Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 14.90
−7.45%Forward multiples
Based on analyst estimates
- P/E forward
- 332.75x
- P/E 2026E
- 443.67x
- P/E 2027E
- 147.89x
- P/E 2028E
- 110.92x
- P/S forward
- 10.11x
Trailing multiples
Trailing twelve months
- P/E TTM
- 134.07x
- PEG TTM
- —
- Price / book
- 3.31x
- Price / sales
- 8.87x
- Price / cash flow
- 33.66x
Enterprise value
- Enterprise value
- CNY 22.0B
- EV / sales
- 9.18x
- EV / EBITDA
- 37.41x
- EV / EBIT
- 66.23x
- Market cap
- CNY 23.8B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026